Methotrexate - METHOTREXATE SODIUM
Navigation: NDC > Supplier starting with: F > FRESENIUS KABI USA, LLC| Field | Value |
|---|---|
| NDC Code: | 63323-122 |
| Proprietary Name: | Methotrexate |
| Suffix: | |
| Non-Proprietary Name: | METHOTREXATE SODIUM |
| Dosage Form: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Original Marketing Date: | 22-01-2000 |
| Category Name: | ANDA |
| Application Number: | ANDA040266 |
| Labeler: | FRESENIUS KABI USA, LLC |
| Substance Name: | METHOTREXATE SODIUM |
| Active Numerator Strength: | 1 |
| Active Ingredient Unit: | g/1 |
| Pharm Classes: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| DEA Schedule: |